Company Encyclopedia
View More
name
Sanyuan Biotechnology
301206.SZ
Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic products; chemical products; and other applications. The company exports its products to Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa.
2.067 T
301206.SZMarket value -Rank by Market Cap -/-

Financial Score

13/12/2025 Update
C
Packaged Foods and MeatsIndustry
Industry Ranking91/137
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE2.07%C
    • Profit Margin13.55%B
    • Gross Margin10.53%E
  • Growth ScoreC
    • Revenue YoY1.63%C
    • Net Profit YoY-4.17%C
    • Total Assets YoY-5.97%D
    • Net Assets YoY-4.69%D
  • Cash ScoreC
    • Cash Flow Margin737.94%B
    • OCF YoY1.63%C
  • Operating ScoreE
    • Turnover0.15E
  • Debt ScoreA
    • Gearing Ratio3.73%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Sanyuan Biotechnology: Shareholder Luxin Capital reduced its holdings by nearly 6 million shares, bringing its stake down to 0.97%

    Sanyuan Biotechnology announced that shareholder Luxin Capital reduced its holdings by nearly 6 million shares, bringing its stake down to 0.97%. From August 7 to October 29, 2025, Luxin Capital reduced its holdings by a total of 5.99005 million shares through block trades and centralized bidding, accounting for 2.995% of the total share capital. This reduction did not result in a change of control of the company and has no significant impact on the company's operations

    Zhitong·
    SZ
    301206
    -0.08%
    Zhitong·
    SZ
    301206
    -0.08%

    Overview of A-share dividends and stock distributions: 18 stocks have their equity registration today

    According to Wind data, today 18 A-shares are undergoing equity registration, all intending to distribute dividends. The equity registration date is October 27. Among them, BINGCHUAN, Bochu, and Yunnan Aluminium have the largest dividend payouts, with distributions of 10.00 yuan, 6.66 yuan, and 3.20 yuan per 10 shares, respectively. In addition, Sanyuan Biotechnology, HUAMING, and RAYHOO MOTOR DIES have also proposed dividend plans, intending to distribute 5.0 yuan, 2.0 yuan, and 1.5 yuan, respectively

    Zhitong·
    SZ
    002270
    +3.47%
    SZ
    002997
    +0.51%
    SZ
    300533
    +1.04%
    Zhitong·
    SZ
    002270
    +3.47%
    SZ
    002997
    +0.51%
    SZ
    300533
    +1.04%

    Sanyuan Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 67.3987 million yuan, a decrease of 16.80%

    Sanyuan Biotechnology released its third-quarter report for 2025, with operating revenue of 476 million yuan for the first three quarters, a year-on-year decrease of 7.54%. The net profit attributable to the parent company was 67.3987 million yuan, a year-on-year decline of 16.80%; the net profit after deducting non-recurring gains and losses was 57.1343 million yuan, a year-on-year decrease of 28.11%. The basic earnings per share were 0.34 yuan

    Zhitong·
    SZ
    301206
    -0.08%
    Zhitong·
    SZ
    301206
    -0.08%

    Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%

    According to the Zhitong Finance APP, Sanyuan Biotechnology released its semi-annual report for 2025, showing an operating income of 318 million yuan, a year-on-year decrease of 15.62%. The net profit attributable to shareholders of the listed company was 57.4819 million yuan, a year-on-year increase of 10.73%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.7566 million yuan, a year-on-year decrease of 4.70%. The basic earnings per share were 0.29 yuan

    Zhitong·
    SZ
    301206
    -0.08%
    Zhitong·
    SZ
    301206
    -0.08%

    US Imposes Nearly 451% Anti-Dumping Duties on Sanyuan Biotechnology's Sweeteners

    The US Commerce Department imposed 450.64% in anti-dumping duties against Shandong Sanyuan Biotechnology's erythritol sweeteners, according to a Wednesday filing with the Shenzhen bourse. The duties follow a preliminary anti-dumping investigation. The Commerce Department will need to enforce a final ruling following further verification, the filing said. Sanyuan Biotech will adjust its export-oriented sales strategy and focus on the domestic market, the filing said.

    Trading View·
    SZ
    301206
    -0.08%
    Trading View·
    SZ
    301206
    -0.08%
    © 2025 Longbridge｜Disclaimer